Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome

This study was undertaken to summarize the current status of the clinicopathologicfactors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjögren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malign...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
1996
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/27378
Acceso en línea:
https://doi.org/10.1016/S0049-0172(96)80019-9
https://repository.urosario.edu.co/handle/10336/27378
Palabra clave:
Sjögren's syndrome
Monoclonality
Non-Hodgkin's lymphoma
Apoptosis
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_b44775f6e4104a152159156666dfbab0
oai_identifier_str oai:repository.urosario.edu.co:10336/27378
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 194747786005446dfb2-0eab-4eb2-902d-83c279cd125c0e8f42d6-f6e7-4ba5-b6c5-59de49ee9fd90fd2df54-029b-4353-8fe9-54f417b2b8d42020-08-19T14:41:57Z2020-08-19T14:41:57Z1996-04This study was undertaken to summarize the current status of the clinicopathologicfactors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjögren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10% of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and crossreactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.application/pdfhttps://doi.org/10.1016/S0049-0172(96)80019-9ISSN: 0049-0172EISSN: 1532-866Xhttps://repository.urosario.edu.co/handle/10336/27378engElsevier346No. 5337Seminars in Arthritis and RheumatismVol. 25Seminars in Arthritis and Rheumatism, ISSN: 0049-0172;EISSN: 1532-866X, Vol.25, No.5 (1996); pp. 337-346https://www.sciencedirect.com/science/article/abs/pii/S0049017296800199?via%3DihubRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecSeminars in Arthritis and Rheumatisminstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURSjögren's syndromeMonoclonalityNon-Hodgkin's lymphomaApoptosisClinicopathological factors relating malignant lymphoma with Sjogren's syndromeFactores clínico-patológicos que relacionan el linfoma maligno con el síndrome de SjogrenarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Anaya, Juan-ManuelMcGuff, H.StanBanks, Peter M.Tala, Norman10336/27378oai:repository.urosario.edu.co:10336/273782021-08-11 21:13:43.43https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
dc.title.TranslatedTitle.spa.fl_str_mv Factores clínico-patológicos que relacionan el linfoma maligno con el síndrome de Sjogren
title Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
spellingShingle Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
Sjögren's syndrome
Monoclonality
Non-Hodgkin's lymphoma
Apoptosis
title_short Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
title_full Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
title_fullStr Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
title_full_unstemmed Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
title_sort Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome
dc.subject.keyword.spa.fl_str_mv Sjögren's syndrome
Monoclonality
Non-Hodgkin's lymphoma
Apoptosis
topic Sjögren's syndrome
Monoclonality
Non-Hodgkin's lymphoma
Apoptosis
description This study was undertaken to summarize the current status of the clinicopathologicfactors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjögren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10% of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and crossreactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.
publishDate 1996
dc.date.created.spa.fl_str_mv 1996-04
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:41:57Z
dc.date.available.none.fl_str_mv 2020-08-19T14:41:57Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/S0049-0172(96)80019-9
dc.identifier.issn.none.fl_str_mv ISSN: 0049-0172
EISSN: 1532-866X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/27378
url https://doi.org/10.1016/S0049-0172(96)80019-9
https://repository.urosario.edu.co/handle/10336/27378
identifier_str_mv ISSN: 0049-0172
EISSN: 1532-866X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 346
dc.relation.citationIssue.none.fl_str_mv No. 5
dc.relation.citationStartPage.none.fl_str_mv 337
dc.relation.citationTitle.none.fl_str_mv Seminars in Arthritis and Rheumatism
dc.relation.citationVolume.none.fl_str_mv Vol. 25
dc.relation.ispartof.spa.fl_str_mv Seminars in Arthritis and Rheumatism, ISSN: 0049-0172;EISSN: 1532-866X, Vol.25, No.5 (1996); pp. 337-346
dc.relation.uri.spa.fl_str_mv https://www.sciencedirect.com/science/article/abs/pii/S0049017296800199?via%3Dihub
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.source.spa.fl_str_mv Seminars in Arthritis and Rheumatism
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167706236092416